Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index; 1 of the 9 sources its claims cite were checked for support.
Abstract
BACKGROUND: The severe acute respiratory syndrome (SARS) has recently been identified as a new clinical entity. SARS is thought to be caused by an unknown infectious agent. METHODS: Clinical specimens from patients with SARS were searched for unknown viruses with the use of cell cultures and molecular techniques. RESULTS: A novel coronavirus was identified in patients with SARS. The virus was isolated in cell culture, and a sequence 300 nucleotides in length was obtained by a polymerase-chain-reaction (PCR)-based random-amplification procedure. Genetic characterization indicated that the virus is only distantly related to known coronaviruses (identical in 50 to 60 percent of the nucleotide sequence). On the basis of the obtained sequence, conventional and real-time PCR assays for specific and sensitive detection of the novel virus were established. Virus was detected in a variety of clinical specimens from patients with SARS but not in controls. High concentrations of viral RNA of up to 100 million molecules per milliliter were found in sputum. Viral RNA was also detected at extremely low concentrations in plasma during the acute phase and in feces during the late convalescent phase. Infected patients showed seroconversion on the Vero cells in which the virus was isolated. CONCLUSIONS: The novel coronavirus might have a role in causing SARS.
Overview
CoChat Summary
## TL;DR
The paper identifies a previously unknown coronavirus in patients with severe acute respiratory syndrome (SARS) and provides PCR and serologic evidence linking it to the illness. It also reports that viral RNA was found at very high levels in sputum, with lower-level detection in plasma and later in stool, supporting a respiratory infection with possible additional shedding routes.
## Key findings
- A novel coronavirus was isolated from sputum of the index patient after 6 days of incubation in Vero-cell culture, and a 300-nucleotide sequence was obtained by random RT-PCR.
- Genetic analysis found the virus was only distantly related to known coronaviruses, with the BNI-1 sequence differing by 39% to 46% from known sequences and by 50% to 60% identical nucleotide sequence to known coronaviruses.
- In the Hanoi outbreak panel, the virus was detected in 100% of patients with probable SARS, 23% of those with suspected SARS, and 0% of healthy contacts.
- Quantitative PCR found viral RNA concentrations of up to 100 million molecules per milliliter in sputum; the index patient also had RNA in plasma at 190 (day 9) and stool on day 25, and Contact 1 had 6.3 × 10^4 in sputum and 4.1 × 10^5 in BAL.
## Methods
- Clinical specimens from SARS patients were screened for known and unknown pathogens using cell culture, electron microscopy, PCR, antigen ELISA, serology, and sequence/phylogenetic analysis.
- The study examined specimens from 3 patients in Frankfurt (index patient, Contact 1, Contact 2) and a panel of 49 specimens from 18 suspected/probable SARS patients and 21 healthy contacts in Hanoi, plus 54 stool controls from Germany.
- A random RT-PCR approach and subsequent nested and real-time RT-PCR assays were developed to identify and quantify the novel virus, with specificity tested against several other coronaviruses.
## Limitations
- The paper itself states that larger studies with appropriate control groups are needed to verify or reject the hypothesis that this virus causes SARS.
- The authors note that the antibody response might not be definitively directed against the novel coronavirus, because the antigen used in serology came from primary cultures; they say this should be tested with plaque-purified virus or recombinant proteins.
- Evidence of causation is not established here; the paper shows association and detection in patients, but the conclusion is only that the virus “might have a role” in causing SARS.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 0 Not valid · 7 Not checked · 67 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The presence of viral RNA in stool of the patients late during convalescence is reminiscent of characteristics of other coronaviruses. 13”
What the sources say
- Partly supportedcites [13] matched to “Evaluation of concurrent shedding of bovine coronavirus via the respiratory tract and enteric route in feedlot cattle” (2001) sourceExperimental — accuracy not yet measured
Our copy of Cho et al (2001) supports only the general point that a bovine coronavirus is present/shed in feces: fecal samples from 56 feedlot steers were positive for BCV by antigen-capture ELISA and virus isolation (Results, p. 1; Materials and Methods, Sample Collections), and the Discussion (p. 6) notes 22% of fecal samples from cattle without diarrhea were antigen-positive, suggesting they 'had diarrhea during shipping or at the auction barn and were still shedding BCV'. The specific elements the citing sentence attributes are absent: detection was of antigen/infectious virus, not viral RNA (no RT-PCR assay appears anywhere in our copy; RT-PCR of feces belongs to a work it cites, Tsunemitsu and Saif, ref 35), samples were taken only on days 0, 4, 14 and 21 after arrival rather than late during convalescence, in cattle rather than human patients, and the paper makes no comparative statement about shared characteristics of other coronaviruses. (LLM, conf=0.62)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Infected patients showed seroconversion on the Vero cells in which the virus was isolated.”
- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“About 20 distinct DNA fragments were obtained and sequenced.”
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Three of the fragments did not match any nucleotide sequence in the data base.”
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“since there was serologic evidence of an acute infection with this virus in our index patient and also in Contact 1”
plainn = 2- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
50 more claims
Create a free account to see all 75 claims and to verify the 7 references still open.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 11
Citations
Cites
PHYLIP-Phylogeny inference package (Version 3.2)
Felsenstein, J. (1989) · Cladistics · Cited by 17,682
Identification of Severe Acute Respiratory Syndrome in Canada
Poutanen, S. M., Low, D. E., Henry, B., Finkelstein, S., Rose, D., Green, K., Tellier, R., Draker, R., Adachi, D., Ayers, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030634 · Cited by 1,132
A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong
Tsang, K. W., Ho, P. L., Ooi, G. C., Yee, W. K., Wang, T., Chan-Yeung, M., Lam, W. K., Seto, W. H., Yam, L. Y., Cheung, T. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030666 · Cited by 1,017
Viruses and bacteria in the etiology of the common cold
Mäkelä, M. J., Puhakka, T., Ruuskanen, O., Leinonen, M., Saikku, P., Kimpimäki, M., Blomqvist, S., Hyypiä, T., & Arstila, P. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.2.539-542.1998 · Cited by 768
Drosten, C., Göttig, S., Schilling, S., Asper, M., Panning, M., Schmitz, H., & Günther, S. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.7.2323-2330.2002 · Cited by 631
Self-citationImported Lassa Fever in Germany: Molecular Characterization of a New Lassa Virus Strain
Günther, S., Emmerich, P., Laue, T., Kühle, O., Asper, M., Jung, A., Grewing, T., ter Meulen, J., & Schmitz, H. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0605.000504 · Cited by 200
Self-citationStephensen, C. B., Casebolt, D. B., & Gangopadhyay, N. N. (1999) · Virus Research · doi:10.1016/s0168-1702(99)00017-9 · Cited by 135
Cho, K.-O., Hoet, A. E., Loerch, S. C., Wittum, T. E., & Saif, L. J. (2001) · American Journal of Veterinary Research · doi:10.2460/ajvr.2001.62.1436 · Cited by 88
TTV a common virus, but pathogenic?
Cossart, Y. E. (1998) · The Lancet · doi:10.1016/s0140-6736(05)77802-8 · Cited by 44
HGV: hepatitis G virus or harmless G virus?
Kew, M. C., & Kassianides, C. (1996) · The Lancet · doi:10.1016/s0140-6736(96)98020-4 · Cited by 39
Research works printed but not linked: 2
- 2003, Wkly Epidemiol Rec, 78, 81
- 2003, Wkly Epidemiol Rec, 78, 73
Cited by
Items 301–400 of 1,020
The Novel Coronavirus: A Bird's Eye View
Habibzadeh, P., & Stoneman, E. K. (2020) · The International Journal of Occupational and Environmental Medicine · doi:10.15171/ijoem.2020.1921 · Cited by 307
Effect of ultraviolet germicidal irradiation on viral aerosols
Walker, C. M., & Ko, G. (2007) · Environmental Science & Technology · doi:10.1021/es070056u · Cited by 308
O'Keefe, B. R., Giomarelli, B., Barnard, D. L., Shenoy, S. R., Chan, P. K. S., McMahon, J. B., Palmer, K. E., Barnett, B. W., Meyerholz, D. K., Wohlford-Lenane, C. L., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02322-09 · Cited by 303
Profile of Specific Antibodies to the SARS-Associated Coronavirus
Li, G., Chen, X., & Xu, A. (2003) · New England Journal of Medicine · doi:10.1056/nejm200307313490520 · Cited by 307
Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics
Ghosh, A. K., Brindisi, M., Shahabi, D., Chapman, M. E., & Mesecar, A. D. (2020) · ChemMedChem · doi:10.1002/cmdc.202000223 · Cited by 306
Egloff, M.-P., Ferron, F., Campanacci, V., Longhi, S., Rancurel, C., Dutartre, H., Snijder, E. J., Gorbalenya, A. E., Cambillau, C., & Canard, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307877101 · Cited by 306
Croup Is Associated with the Novel Coronavirus NL63
van der Hoek, L., Sure, K., Ihorst, G., Stang, A., Pyrc, K., Jebbink, M. F., Petersen, G., Forster, J., Berkhout, B., & Überla, K. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020240 · Cited by 308
HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus
Yamamoto, N., Yang, R., Yoshinaka, Y., Amari, S., Nakano, T., Cinatl, J., Rabenau, H., Doerr, H. W., Hunsmann, G., Otaka, A., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.083 · Cited by 306
Self-citationGhosh, R., Chakraborty, A., Biswas, A., & Chowdhuri, S. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1779818 · Cited by 301
Josset, L., Menachery, V. D., Gralinski, L. E., Agnihothram, S., Sova, P., Carter, V. S., Yount, B. L., Graham, R. L., Baric, R. S., & Katze, M. G. (2013) · mBio · doi:10.1128/mbio.00165-13 · Cited by 293
Wang, Q., Zhang, L., Kuwahara, K., Li, L., Liu, Z., Li, T., Zhu, H., Liu, J., Xu, Y., Xie, J., et al. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00006 · Cited by 304
Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome
Reghunathan, R., Jayapal, M., Hsu, L.-Y., Chng, H.-H., Tai, D., Leung, B. P., & Melendez, A. J. (2005) · BMC Immunology · doi:10.1186/1471-2172-6-2 · Cited by 300
Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
Coleman, C. M., Liu, Y. V., Mu, H., Taylor, J. K., Massare, M., Flyer, D. C., Glenn, G. M., Smith, G. E., & Frieman, M. B. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.04.016 · Cited by 293
Clinical impact and diagnosis of human metapneumovirus infection
VAN DEN HOOGEN, B. G., OSTERHAUS, D. M. E., & FOUCHIER, R. A. M. (2004) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000108190.09824.e8 · Cited by 297
Self-citationNosocomial Transmission of Emerging Viruses via Aerosol-Generating Medical Procedures
Judson, S. D., & Munster, V. J. (2019) · Viruses · doi:10.3390/v11100940 · Cited by 294
SARS coronavirus E protein forms cation-selective ion channels
Wilson, L., Mckinlay, C., Gage, P., & Ewart, G. (2004) · Virology · doi:10.1016/j.virol.2004.09.033 · Cited by 293
Yoshikawa, T., Hill, T., Li, K., Peters, C. J., & Tseng, C.-T. K. (2009) · Journal of Virology · doi:10.1128/jvi.01792-08 · Cited by 293
Application of next-generation sequencing technologies in virology
Radford, A. D., Chapman, D., Dixon, L., Chantrey, J., Darby, A. C., & Hall, N. (2012) · Journal of General Virology · doi:10.1099/vir.0.043182-0 · Cited by 291
Mirza, M. U., & Froeyen, M. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2020.04.008 · Cited by 284
Tan, J., Mu, L., Huang, J., Yu, S., Chen, B., & Yin, J. (2005) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2004.020180 · Cited by 292
Insights into SARS-CoV transcription and replication from the structure of the nsp7–nsp8 hexadecamer
Zhai, Y., Sun, F., Li, X., Pang, H., Xu, X., Bartlam, M., & Rao, Z. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb999 · Cited by 290
COVID-19 Pandemic and Comparative Health Policy Learning in Iran
Raoofi, A., Takian, A., Akbari Sari, A., Olyaeemanesh, A., Haghighi, H., & Aarabi, M. (2020) · Archives of Iranian Medicine · doi:10.34172/aim.2020.02 · Cited by 294
Chowell, G., Fenimore, P. W., Castillo-Garsow, M. A., & Castillo-Chavez, C. (2003) · Journal of Theoretical Biology · doi:10.1016/s0022-5193(03)00228-5 · Cited by 292
Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis
Ng, W. H., Tipih, T., Makoah, N. A., Vermeulen, J.-G., Goedhals, D., Sempa, J. B., Burt, F. J., Taylor, A., & Mahalingam, S. (2021) · mBio · doi:10.1128/mbio.03647-20 · Cited by 288
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies
Zhu, Z., Chakraborti, S., He, Y., Roberts, A., Sheahan, T., Xiao, X., Hensley, L. E., Prabakaran, P., Rockx, B., Sidorov, I. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701000104 · Cited by 287
Albahri, A. S., Hamid, R. A., Alwan, J. K., Al-qays, Z. T., Zaidan, A. A., Zaidan, B. B., Albahri, A. O. S., AlAmoodi, A. H., Khlaf, J. M., Almahdi, E. M., et al. (2020) · Journal of Medical Systems · doi:10.1007/s10916-020-01582-x · Cited by 278
Mannose-Binding Lectin in Severe Acute Respiratory Syndrome Coronavirus Infection
Ip, W. K. E., Chan, K. H., Law, H. K. W., Tso, G. H. W., Kong, E. K. P., Wong, W. H. S., To, Y. F., Yung, R. W. H., Chow, E. Y., Au, K. L., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/429631 · Cited by 284
Liu, W., Fontanet, A., Zhang, P., Zhan, L., Xin, Z., Baril, L., Tang, F., Lv, H., & Cao, W. (2006) · The Journal of Infectious Diseases · doi:10.1086/500469 · Cited by 285
Bats, Civets and the Emergence of SARS
Wang, L. F., & Eaton, B. T. (2007) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-70962-6_13 · Cited by 271
Desforges, M., Le Coupanec, A., Brison, É., Meessen-Pinard, M., & Talbot, P. J. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-81-322-1777-0_6 · Cited by 281
Yang, D., Xu, Z., Li, W., Myronenko, A., Roth, H. R., Harmon, S., Xu, S., Turkbey, B., Turkbey, E., Wang, X., et al. (2021) · Medical Image Analysis · doi:10.1016/j.media.2021.101992 · Cited by 279
“However, this technique can have high false negative/positive rate for coronavirus due to multi-factorial issues (Drosten et al., 2003).”
Spiegel, M., Pichlmair, A., Martínez-Sobrido, L., Cros, J., García-Sastre, A., Haller, O., & Weber, F. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2079-2086.2005 · Cited by 279
Severe Acute Respiratory Syndrome Coronavirus Infection of Golden Syrian Hamsters
Roberts, A., Vogel, L., Guarner, J., Hayes, N., Murphy, B., Zaki, S., & Subbarao, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.503-511.2005 · Cited by 285
Li, T., Qiu, Z., Zhang, L., Han, Y., He, W., Liu, Z., Ma, X., Fan, H., Lu, W., Xie, J., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/381535 · Cited by 282
Seyed Hosseini, E., Riahi Kashani, N., Nikzad, H., Azadbakht, J., Hassani Bafrani, H., & Haddad Kashani, H. (2020) · Virology · doi:10.1016/j.virol.2020.08.011 · Cited by 273
Cilla, G., Oñate, E., Perez‐Yarza, E. G., Montes, M., Vicente, D., & Perez‐Trallero, E. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21271 · Cited by 276
COVID–19-associated coagulopathy: An exploration of mechanisms
Colling, M. E., & Kanthi, Y. (2020) · Vascular Medicine · doi:10.1177/1358863x20932640 · Cited by 278
Treatment of Severe Acute Respiratory Syndrome With Glucosteroids
Chen, R.-C., Tang, X.-P., Tan, S.-Y., Liang, B.-L., Wan, Z.-Y., Fang, J.-Q., & Zhong, N. (2006) · Chest · doi:10.1378/chest.129.6.1441 · Cited by 274
Identification of a Novel Coronavirus from a Beluga Whale by Using a Panviral Microarray
Mihindukulasuriya, K. A., Wu, G., St. Leger, J., Nordhausen, R. W., & Wang, D. (2008) · Journal of Virology · doi:10.1128/jvi.02722-07 · Cited by 279
Human coronaviruses: Viral and cellular factors involved in neuroinvasiveness and neuropathogenesis
Desforges, M., Le Coupanec, A., Stodola, J. K., Meessen-Pinard, M., & Talbot, P. J. (2014) · Virus Research · doi:10.1016/j.virusres.2014.09.011 · Cited by 275
Possible SARS Coronavirus Transmission during Cardiopulmonary Resuscitation
Christian, M. D., Loutfy, M., McDonald, L. C., Martinez, K. F., Ofner, M., Wong, T., Wallington, T., Gold, W. L., Mederski, B., Green, K., et al. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1002.030700 · Cited by 274
Li, W., Wong, S.-K., Li, F., Kuhn, J. H., Huang, I.-C., Choe, H., & Farzan, M. (2006) · Journal of Virology · doi:10.1128/jvi.80.9.4211-4219.2006 · Cited by 276
Lau, S. K. P., Li, K. S. M., Huang, Y., Shek, C.-T., Tse, H., Wang, M., Choi, G. K. Y., Xu, H., Lam, C. S. F., Guo, R., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02219-09 · Cited by 273
Deming, D., Sheahan, T., Heise, M., Yount, B., Davis, N., Sims, A., Suthar, M., Harkema, J., Whitmore, A., Pickles, R., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030525 · Cited by 275
Efficacy of various disinfectants against SARS coronavirus
Rabenau, H. F., Kampf, G., Cinatl, J., & Doerr, H. W. (2005) · Journal of Hospital Infection · doi:10.1016/j.jhin.2004.12.023 · Cited by 271
Self-citationDetection of SARS-associated Coronavirus in Throat Wash and Saliva in Early Diagnosis
Wang, W.-K., Chen, S.-Y., Liu, I.-J., Chen, Y.-C., Chen, H.-L., Yang, C.-F., Chen, P.-J., Yeh, S.-H., Kao, C.-L., Huang, L.-M., et al. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1007.031113 · Cited by 266
Chong, P. Y., Chui, P., Ling, A. E., Franks, T. J., Tai, D. Y. H., Leo, Y. S., Kaw, G. J. L., Wansaicheong, G., Chan, K. P., Ean Oon, L. L., et al. (2004) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2004-128-195-aoddts · Cited by 270
The coronavirus proofreading exoribonuclease mediates extensive viral recombination
Gribble, J., Stevens, L. J., Agostini, M. L., Anderson-Daniels, J., Chappell, J. D., Lu, X., Pruijssers, A. J., Routh, A. L., & Denison, M. R. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009226 · Cited by 279
Monocytes and Macrophages in COVID-19
Knoll, R., Schultze, J. L., & Schulte-Schrepping, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.720109 · Cited by 266
Viral Loads in Clinical Specimens and SARS Manifestations
Hung, I. F. N., Cheng, V. C. C., Wu, A. K. L., Tang, B. S. F., Chan, K. H., Chu, C. M., Wong, M. M. L., Hui, W. T., Poon, L. L. M., Tse, D. M. W., et al. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1009.040058 · Cited by 270
Architecture and self‐assembly of the SARS‐CoV ‐2 nucleocapsid protein
Ye, Q., West, A. M. V., Silletti, S., & Corbett, K. D. (2020) · Protein Science · doi:10.1002/pro.3909 · Cited by 277
Cornillez-Ty, C. T., Liao, L., Yates, J. R., Kuhn, P., & Buchmeier, M. J. (2009) · Journal of Virology · doi:10.1128/jvi.00842-09 · Cited by 271
Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs
Tompa, D. R., Immanuel, A., Srikanth, S., & Kadhirvel, S. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.076 · Cited by 257
Guttmacher, A. E., & Collins, F. S. (2003) · New England Journal of Medicine · doi:10.1056/nejme038132 · Cited by 262
Mechanism of the Maturation Process of SARS-CoV 3CL Protease
Hsu, M.-F., Kuo, C.-J., Chang, K.-T., Chang, H.-C., Chou, C.-C., Ko, T.-P., Shr, H.-L., Chang, G.-G., Wang, A. H.-J., & Liang, P.-H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502577200 · Cited by 262
Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase
Newman, J. A., Douangamath, A., Yadzani, S., Yosaatmadja, Y., Aimon, A., Brandão-Neto, J., Dunnett, L., Gorrie-stone, T., Skyner, R., Fearon, D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25166-6 · Cited by 256
The Novel Human Coronaviruses NL63 and HKU1
Pyrc, K., Berkhout, B., & van der Hoek, L. (2007) · Journal of Virology · doi:10.1128/jvi.01466-06 · Cited by 260
Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein
Nieto-Torres, J. L., DeDiego, M. L., Álvarez, E., Jiménez-Guardeño, J. M., Regla-Nava, J. A., Llorente, M., Kremer, L., Shuo, S., & Enjuanes, L. (2011) · Virology · doi:10.1016/j.virol.2011.03.029 · Cited by 262
Hung, P. J., Lee, P. J., Sabounchi, P., Aghdam, N., Lin, R., & Lee, L. P. (2005) · Lab on a Chip · doi:10.1039/b410743h · Cited by 259
SARS-CoV-2 Productively Infects Human Gut Enterocytes
Lamers, M. M., Beumer, J., van der Vaart, J., Knoops, K., Puschhof, J., Breugem, T. I., Ravelli, R. B. G., van Schayck, J. P., Mykytyn, A. Z., Duimel, H. Q., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.25.060350 · Cited by 259
Pfefferle, S., Oppong, S., Drexler, J. F., Gloza-Rausch, F., Ipsen, A., Seebens, A., Müller, M. A., Annan, A., Vallo, P., Adu-Sarkodie, Y., et al. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1509.090224 · Cited by 249
Self-citationAhmad, A., Banat, F., Alsafar, H., & Hasan, S. W. (2022) · Science of The Total Environment · doi:10.1016/j.scitotenv.2021.150585 · Cited by 256
He, Z., Zhao, C., Dong, Q., Zhuang, H., Song, S., Peng, G., & Dwyer, D. E. (2005) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2004.07.014 · Cited by 258
Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice
Becker, M. M., Graham, R. L., Donaldson, E. F., Rockx, B., Sims, A. C., Sheahan, T., Pickles, R. J., Corti, D., Johnston, R. E., Baric, R. S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808116105 · Cited by 264
Bukreyev, A., Lamirande, E. W., Buchholz, U. J., Vogel, L. N., Elkins, W. R., Claire, M. S., Murphy, B. R., Subbarao, K., & Collins, P. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16501-x · Cited by 256
Hsueh, P.-R., Huang, L.-M., Chen, P.-J., Kao, C.-L., & Yang, P.-C. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01009.x · Cited by 261
Chen, C.-Y., Chang, C.-K., Chang, Y.-W., Sue, S.-C., Bai, H.-I., Riang, L., Hsiao, C.-D., & Huang, T.-H. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.02.069 · Cited by 260
Human Coronavirus NL63, France
Vabret, A., Mourez, T., Dina, J., van der Hoek, L., Gouarin, S., Petitjean, J., Brouard, J., & Freymuth, F. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1108.050110 · Cited by 252
Hofmann, H., Geier, M., Marzi, A., Krumbiegel, M., Peipp, M., Fey, G. H., Gramberg, T., & Pöhlmann, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.114 · Cited by 257
SARS: The First Pandemic of the 21st Century
Cherry, J. D., & Krogstad, P. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000129184.87042.fc · Cited by 248
Minakshi, R., Padhan, K., Rani, M., Khan, N., Ahmad, F., & Jameel, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008342 · Cited by 257
Xue, X., Yang, H., Shen, W., Zhao, Q., Li, J., Yang, K., Chen, C., Jin, Y., Bartlam, M., & Rao, Z. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.11.073 · Cited by 260
Crystal Structure of Severe Acute Respiratory Syndrome Coronavirus Spike Protein Fusion Core
Xu, Y., Lou, Z., Liu, Y., Pang, H., Tien, P., Gao, G. F., & Rao, Z. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408782200 · Cited by 252
Chen, J., & Subbarao, K. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141706 · Cited by 251
Fc receptors in antibody‐dependent enhancement of viral infections
Taylor, A., Foo, S., Bruzzone, R., Vu Dinh, L., King, N. J. C., & Mahalingam, S. (2015) · Immunological Reviews · doi:10.1111/imr.12367 · Cited by 255
CORONAVIRUS DISEASE 2019 (COVID-19): A LITERATURE REVIEW
Ibrahim, B., & Önem, E. (2021) · Gevher Nesibe Journal IESDR · doi:10.46648/gnj.200 · Cited by 239
Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses
Yang, Z.-Y., Werner, H. C., Kong, W.-P., Leung, K., Traggiai, E., Lanzavecchia, A., & Nabel, G. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409065102 · Cited by 253
Yount, B., Roberts, R. S., Sims, A. C., Deming, D., Frieman, M. B., Sparks, J., Denison, M. R., Davis, N., & Baric, R. S. (2005) · Journal of Virology · doi:10.1128/jvi.79.23.14909-14922.2005 · Cited by 253
Kuhn, J. H., Li, W., Choe, H., & Farzan, M. (2004) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-004-4242-5 · Cited by 249
Inhibition of SARS–CoV-2 by type I and type III interferons
Felgenhauer, U., Schoen, A., Gad, H. H., Hartmann, R., Schaubmar, A. R., Failing, K., Drosten, C., & Weber, F. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ac120.013788 · Cited by 246
Self-citationYasui, F., Kai, C., Kitabatake, M., Inoue, S., Yoneda, M., Yokochi, S., Kase, R., Sekiguchi, S., Morita, K., Hishima, T., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6337 · Cited by 252
Decroly, E., Imbert, I., Coutard, B., Bouvet, M., Selisko, B., Alvarez, K., Gorbalenya, A. E., Snijder, E. J., & Canard, B. (2008) · Journal of Virology · doi:10.1128/jvi.00407-08 · Cited by 252
World Journal of Pharmaceutical Sciences
(2021) · World Journal of Pharmaceutical Sciences · doi:10.54037/wjps · Cited by 245
Oudshoorn, D., Rijs, K., Limpens, R. W. A. L., Groen, K., Koster, A. J., Snijder, E. J., Kikkert, M., & Bárcena, M. (2017) · mBio · doi:10.1128/mbio.01658-17 · Cited by 245
Molecular biology of severe acute respiratory syndrome coronavirus
Ziebuhr, J. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2004.06.007 · Cited by 241
Resolution of coronavirus disease 2019 (COVID-19)
Habas, K., Nganwuchu, C., Shahzad, F., Gopalan, R., Haque, M., Rahman, S., Majumder, A. A., & Nasim, T. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1797487 · Cited by 231
Inhibition of SARS‐CoV 3C‐like Protease Activity by Theaflavin‐3,3′‐digallate (TF3)
Chen, C.-N., Lin, C. P. C., Huang, K.-K., Chen, W.-C., Hsieh, H.-P., Liang, P.-H., & Hsu, J. T.-A. (2005) · Evidence-Based Complementary and Alternative Medicine · doi:10.1093/ecam/neh081 · Cited by 239
Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS)
Tse, G. M.-K., To, K.-F., Chan, P. K.-S., Lo, A. W. I., Ng, K.-C., Wu, A., Lee, N., Wong, H.-C., Mak, S.-M., Chan, K.-F., et al. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.013276 · Cited by 238
Babcock, G. J., Esshaki, D. J., Thomas, W. D., & Ambrosino, D. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4552-4560.2004 · Cited by 243
Cellular entry of the SARS coronavirus
Hofmann, H., & Pöhlmann, S. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.08.008 · Cited by 237
Qian, Z., Dominguez, S. R., & Holmes, K. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076469 · Cited by 242
He, Y., Lu, H., Siddiqui, P., Zhou, Y., & Jiang, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4908 · Cited by 241
SARS coronavirus: a new challenge for prevention and therapy
Holmes, K. V. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18819 · Cited by 223
Moore, M. J., Dorfman, T., Li, W., Wong, S. K., Li, Y., Kuhn, J. H., Coderre, J., Vasilieva, N., Han, Z., Greenough, T. C., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10628-10635.2004 · Cited by 243
Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs
Tan, E. L. C., Ooi, E. E., Lin, C.-Y., Tan, H. C., Ling, A. E., Lim, B., & Stanton, L. W. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1004.030458 · Cited by 237
Neurological manifestations in severe acute respiratory syndrome.
Tsai, L., Hsieh, S., & Chang, Y. (2005) · PubMed · Cited by 235
Prabakaran, P., Gan, J., Feng, Y., Zhu, Z., Choudhry, V., Xiao, X., Ji, X., & Dimitrov, D. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600697200 · Cited by 238
Is the kidney a target of SARS-CoV-2?
Martinez-Rojas, M. A., Vega-Vega, O., & Bobadilla, N. A. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00160.2020 · Cited by 237
Advanced Point‐of‐Care Testing Technologies for Human Acute Respiratory Virus Detection
Zhang, Z., Ma, P., Ahmed, R., Wang, J., Akin, D., Soto, F., Liu, B., Li, P., & Demirci, U. (2022) · Advanced Materials · doi:10.1002/adma.202103646 · Cited by 231
Follis, K. E., York, J., & Nunberg, J. H. (2006) · Virology · doi:10.1016/j.virol.2006.02.003 · Cited by 231
Metadata
- Authors
- Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., Berger, A., Burguière, A.-M., Cinatl, J., Eickmann, M., Escriou, N., Grywna, K., Kramme, S., Manuguerra, J.-C., Müller, S., Rickerts, V., Stürmer, M., Vieth, S., Klenk, H.-D., Osterhaus, A. D. M. E., Schmitz, H., & Doerr, H. W.
- Affiliations
- Goethe University Frankfurt (DE)
- From the Bernhard Nocht Institute for Tropical Medicine, National Reference Center for Tropical Infectious Diseases, Hamburg (C.D., S.G., M.P., K.G., S.K., S.M., S.V., H.S.); the Institute of Medical Virology (W.P., H.R., A.B., J.C., M.S., H.W.D.) and the Medical Clinic III (H.-R.B., V.R.), Johann Wolfgang Goethe University, Frankfurt am Main; and the Institute of Virology, Philipps University, Marburg (S.B., L.K., M.E., H.-D.K.) — all in Germany; the Pasteur Institute, Molecular Genetics of Respiratory...
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-05-15
- Volume
- 348
- Issue
- 20
- Pages
- 1967-1976
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2132260239
- Semantic Scholar
- 79116f5bb552a1a23de85d03899ab0b3763c81ee
- Cited by
- 4,574
- References
- 10
- Citations by year
- 2026: 40 · 2025: 91 · 2024: 141 · 2023: 193 · 2022: 361 · 2021: 646 · 2020: 913 · 2019: 50 · 2018: 45 · 2017: 49 · 2016: 60 · 2015: 65 · 2014: 91 · 2013: 83 · 2012: 93
- FWCI
- 222.93
- Type
- journal article
- Language
- en
- Open access
- green
- pure.eur.nl
- Licence
- other-oa
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS, novel coronavirus, SARS-CoV, virus identification, viral RNA detection, seroconversion, fecal viral shedding, plasma viral RNA
- MeSH terms
- Adult, Amino Acid Sequence, Animals, Base Sequence, Cattle, Disease Outbreaks, DNA, Viral, Female, Humans, Male, Molecular Sequence Data, Phylogeny, RNA, Viral, Sequence Homology, Nucleic Acid, Sputum, Polymerase Chain Reaction, Coronavirus, Severe Acute Respiratory Syndrome, Severe acute respiratory syndrome-related coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.